Publications by authors named "Wen-Yo Tu"

Article Synopsis
  • Motor neurons are specialized cells that send signals over long distances to connect with muscles through neuromuscular junctions (NMJs), but local translation of proteins at these junctions hasn't been fully understood.
  • Recent research using advanced techniques identified that specific mRNAs linked to energy production and synaptic function are localized and translated at NMJs, which change focus from building structures in development to energy production in adulthood.
  • The study highlights the importance of the mRNA encoding Agrin at motor axon terminals; disrupting its local translation negatively affects motor function and synaptic transmission, implying that precise regulation at NMJs is crucial for proper muscle control.
View Article and Find Full Text PDF

Expansion of the hexanucleotide repeat GGGGCC in the C9orf72 gene is the most common genetic factor in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Poly-Gly-Ala (poly-GA), one form of dipeptide repeat proteins (DPRs) produced from GGGGCC repeats, tends to form neurotoxic protein aggregates. The C9orf72 GGGGCC repeats and microglial receptor TREM2 are both associated with risk for ALS/FTD.

View Article and Find Full Text PDF
Article Synopsis
  • Amyotrophic lateral sclerosis (ALS) is a severe motoneuron disease characterized by the loss of control over skeletal muscles, beginning with degeneration at neuromuscular junctions (NMJs).
  • Dipeptide repeat proteins (DPRs) linked to the C9orf72 gene mutation are implicated in C9-ALS, but their role may extend beyond direct cellular effects to influence neighboring cells.
  • Our research reveals that the poly-GA form of DPR is released from cells and disrupts NMJ integrity, leading to muscle weakness and impaired signaling by interfering with Agrin-MuSK pathways, suggesting targeting NMJs could be a promising early treatment approach.
View Article and Find Full Text PDF

Background: Neuromuscular junctions (NMJs) are peripheral synapses connecting motoneurons and skeletal myofibers. At the postsynaptic side in myofibers, acetylcholine receptor (AChR) proteins are clustered by the neuronal agrin signal. Meanwhile, several nuclei in each myofiber are specially enriched around the NMJ for postsynaptic gene transcription.

View Article and Find Full Text PDF

Expansion of a hexanucleotide repeat GGGGCC (G4C2) in the intron of the C9ORF72 gene is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (C9-ALS/FTD). Transcripts carrying G4C2 repeat expansions generate neurotoxic dipeptide repeat (DPR) proteins, including poly-Gly-Ala (poly-GA), which tends to form protein aggregates. Here, we demonstrate that UBQLN2, another ALS/FTD risk factor, is recruited to reduce poly-GA aggregates and alleviate poly-GA-induced neurotoxicity.

View Article and Find Full Text PDF

Background: Investigation of neuromuscular junction (NMJ) morphology by immunochemistry can provide important insights into the physiological and pathological status of neuromuscular disorders. Sectioning and muscle fiber tearing are commonly required to prepare experimentally accessible samples, while muscles that are flat and thin can be investigated with whole-mount immunohistochemistry for a comprehensive overview of the entire innervation pattern. The diaphragm is important for respiratory function and one of the flat muscles frequently used for studying neuromuscular development as well as neuromuscular pathology.

View Article and Find Full Text PDF

The neuromuscular junction (NMJ) is a synapse between motoneurons and skeletal muscles to control motor behavior. Acetylcholine receptors (AChRs) are restricted at the synaptic region for proper neurotransmission. Mutations in the mitochondrial CHCHD10 protein have been identified in multiple neuromuscular disorders; however, the physiological roles of CHCHD10 at NMJs remain elusive.

View Article and Find Full Text PDF

Degeneration and loss of lower motor neurons is the major pathological hallmark of spinal muscular atrophy (SMA), resulting from low levels of ubiquitously-expressed survival motor neuron (SMN) protein. One remarkable, yet unresolved, feature of SMA is that not all motor neurons are equally affected, with some populations displaying a robust resistance to the disease. Here, we demonstrate that selective vulnerability of distinct motor neuron pools arises from fundamental modifications to their basal molecular profiles.

View Article and Find Full Text PDF

Spinal muscular atrophy (SMA), a leading genetic cause of infant death, is a neurodegenerative disease characterised by the selective loss of particular groups of motor neurones in the anterior horn of the spinal cord with concomitant muscle weakness. To date, no effective treatment is available, however, there are ongoing clinical trials are in place which promise much for the future. However, there remains an ongoing problem in trying to link a single gene loss to motor neurone degeneration.

View Article and Find Full Text PDF

The ribosomal protein Rpl12p of Saccharomyces cerevisiae is encoded by duplicated genes, RPL12A and RPL12B. The gene products possess an identical amino acid sequence. Yeast strain 6EA1, which lacks both genes, is viable but exhibits a very slow-growth phenotype.

View Article and Find Full Text PDF